Status and phase
Conditions
Treatments
About
Evaluate the efficacy of flexibly-dosed dasotraline compared with placebo in adults with moderate to severe Binge Eating Disorder (BED)
Full description
This is a randomized, double blind, parallel group, multicenter, outpatient study evaluating the efficacy and safety of flexibly-dosed dasotraline in adults with BED using dasotraline (4, 6, and 8 mg/day) versus placebo over a 12 week treatment period.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Subject can read well enough to understand the informed consent form and other subject materials.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
319 participants in 2 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal